Adage Capital Partners’s Spyre Therapeutics SYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.13M | Sell |
610,200
-193,000
| -24% | -$2.89M | 0.02% | 632 |
|
|
2025
Q1 | $13M | Sell |
803,200
-226,800
| -22% | -$3.66M | 0.02% | 528 |
|
|
2024
Q4 | $24M | Sell |
1,030,000
-25,000
| -2% | -$582K | 0.04% | 396 |
|
|
2024
Q3 | $31M | Sell |
1,055,000
-97,411
| -8% | -$2.86M | 0.05% | 331 |
|
|
2024
Q2 | $27.1M | Buy |
1,152,411
+47,211
| +4% | +$1.11M | 0.05% | 361 |
|
|
2024
Q1 | $41.9M | Buy |
1,105,200
+105,200
| +11% | +$3.99M | 0.08% | 267 |
|
|
2023
Q4 | $21.5M | Buy |
+1,000,000
| New | +$21.5M | 0.04% | 408 |
|
|
2023
Q2 | – | Sell |
-60,000
| Closed | -$435K | – | 925 |
|
|
2023
Q1 | $435K | Hold |
60,000
| – | – | ﹤0.01% | 820 |
|
|
2022
Q4 | $675K | Hold |
60,000
| – | – | ﹤0.01% | 855 |
|
|
2022
Q3 | $789K | Hold |
60,000
| – | – | ﹤0.01% | 898 |
|
|
2022
Q2 | $758K | Buy |
+60,000
| New | +$758K | ﹤0.01% | 933 |
|
|
2022
Q1 | – | Sell |
-40,000
| Closed | -$4.75M | – | 1132 |
|
|
2021
Q4 | $4.75M | Sell |
40,000
-100,000
| -71% | -$11.9M | 0.01% | 821 |
|
|
2021
Q3 | $27.8M | Buy |
140,000
+18,017
| +15% | +$3.58M | 0.05% | 352 |
|
|
2021
Q2 | $21.2M | Buy |
121,983
+4,057
| +3% | +$706K | 0.04% | 446 |
|
|
2021
Q1 | $23.3M | Sell |
117,926
-1,754
| -1% | -$347K | 0.05% | 393 |
|
|
2020
Q4 | $23.5M | Hold |
119,680
| – | – | 0.05% | 379 |
|
|
2020
Q3 | $21.2M | Buy |
119,680
+4,000
| +3% | +$709K | 0.05% | 358 |
|
|
2020
Q2 | $26.8M | Buy |
115,680
+56,936
| +97% | +$13.2M | 0.07% | 312 |
|
|
2020
Q1 | $6.84M | Hold |
58,744
| – | – | 0.02% | 532 |
|
|
2019
Q4 | $11.2M | Hold |
58,744
| – | – | 0.03% | 519 |
|
|
2019
Q3 | $11.3M | Hold |
58,744
| – | – | 0.03% | 500 |
|
|
2019
Q2 | $10.1M | Hold |
58,744
| – | – | 0.03% | 531 |
|
|
2019
Q1 | $11.8M | Buy |
58,744
+400
| +0.7% | +$80.5K | 0.03% | 496 |
|
|
2018
Q4 | $10.9M | Buy |
58,344
+21,716
| +59% | +$4.07M | 0.03% | 491 |
|
|
2018
Q3 | $8.76M | Buy |
36,628
+1,000
| +3% | +$239K | 0.02% | 564 |
|
|
2018
Q2 | $9.42M | Buy |
35,628
+25,628
| +256% | +$6.78M | 0.02% | 573 |
|
|
2018
Q1 | $2.48M | Buy |
+10,000
| New | +$2.48M | 0.01% | 669 |
|